![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Cataloguing the Impact of Y93 Substitutions on
HCV NS5A Inhibitor Susceptibility
|
|
|
Reported by Jules Levin
CROI Feb 2017 Seattle WA
Alicia Newton, Charity Ting, Arne Frantzell,
Jennifer Cook, Christos J Petropoulos and Wei Huang
Monogram Biosciences, Laboratory Corporation of America® Holdings
South San Francisco, CA, USA.
![0503171](../images/050317/050317-2/0503171.gif)
![0503172](../images/050317/050317-2/0503172.gif)
![0503173](../images/050317/050317-2/0503173.gif)
![0503174](../images/050317/050317-2/0503174.gif)
![0503175](../images/050317/050317-2/0503175.gif)
![0503176](../images/050317/050317-2/0503176.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|